| Detected | Trial | Change |
|---|---|---|
| 2026-06-10 | NCT05177211 Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic… |
Trial completed |
| 2026-06-10 | NCT05177211 Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic… |
date change Completion moved earlier: 2026-04 -> 2026-01-09 |
| 2026-06-10 | NCT04955730 NPWT in Patients Undergoing Surgical Procedures for Management of GI Malignancies |
Trial completed |
| 2026-06-10 | NCT04955730 NPWT in Patients Undergoing Surgical Procedures for Management of GI Malignancies |
date change Completion moved earlier: 2026-03 -> 2025-09-23 |
| 2026-06-02 | NCT05664178 Remote Resistance Exercise Powering Survivors - Gastrointestinal Oncology |
Trial completed |
| 2026-06-02 | NCT05664178 Remote Resistance Exercise Powering Survivors - Gastrointestinal Oncology |
Enrollment reduced: 100 -> 22 participants |
| 2026-06-02 | NCT05664178 Remote Resistance Exercise Powering Survivors - Gastrointestinal Oncology |
date change Primary completion moved earlier: 2026-08-22 -> 2026-02-03 |
| 2026-06-02 | NCT05664178 Remote Resistance Exercise Powering Survivors - Gastrointestinal Oncology |
date change Completion moved earlier: 2026-08-22 -> 2026-02-03 |
| 2026-05-27 | NCT06337552 High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-27 | NCT06337552 High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED… |
Enrollment reduced: 54 -> 39 participants |
| 2026-05-27 | NCT04588545 Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-27 | NCT04588545 Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast… |
Enrollment reduced: 39 -> 33 participants |
| 2026-05-27 | NCT04588545 Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast… |
date change Primary completion pushed: 2026-08 -> 2027-04 |
| 2026-05-27 | NCT04588545 Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast… |
date change Completion pushed: 2026-08 -> 2027-05 |
| 2026-05-23 | NCT07218848 ProSalud in Latinos Living in Rural/Agricultural Communities Within Moffitt's Catchment… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-23 | NCT07218848 ProSalud in Latinos Living in Rural/Agricultural Communities Within Moffitt's Catchment… |
date change Primary completion pushed: 2026-10 -> 2027-04 |
| 2026-05-23 | NCT07218848 ProSalud in Latinos Living in Rural/Agricultural Communities Within Moffitt's Catchment… |
date change Completion pushed: 2026-10 -> 2027-04 |
| 2026-05-21 | NCT06855212 Phase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing Surgery for… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-21 | NCT04879940 Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization |
date change Primary completion moved earlier: 2026-08 -> 2026-06-13 |
| 2026-05-21 | NCT04879940 Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization |
date change Completion pushed: 2026-08 -> 2027-02 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-10 | NCT07638150 PRehabilitation Intervention to Modify Eating for Breast Cancer Patients (PRIME) | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07357298 | Phase III Trial of Brain MRI Surveillance in Stage IV Breast Cancer | Breast Cancer | Recruiting |
| Phase 2/3 | |||
| NCT03495427 | PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher… | Prostate Cancer | Recruiting |
| Phase 2 | |||
| NCT06350318 | Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas | Follicular Lymphoma | Recruiting |
| NCT05528133 | Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer | Triple Negative Breast Cancer | Recruiting |
| NCT06088498 | App for Reducing Cravings to Smoke | Smoking | Recruiting |
| NCT06109467 | Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2… | GastroEsophageal Cancer | Recruiting |
| NCT06511882 | Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD | Acute Myeloid Leukemia | Recruiting |
| NCT06701812 | Digoxin Medulloblastoma Study | Medulloblastoma | Recruiting |
| NCT05325632 | Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab &… | HER2-positive Breast Cancer | Recruiting |
| NCT05751941 | Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic… | Prostate Cancer | Recruiting |
| NCT05757219 | Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy | Diffuse Large B Cell Lymphoma | Recruiting |
| NCT06104592 | Single-Arm Comprehensive Ablative Bridging Irradiation I Prior to CD19 CAR-T In High-Risk… | Large B-cell Lymphoma | Recruiting |
| NCT06144606 | Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic… | B-Cell Lymphoblastic Leukemia | Recruiting |
| NCT06553872 | Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R… | Mantle Cell Lymphoma | Recruiting |
| NCT07276386 | Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal… | Metastatic Uveal Melanoma | Recruiting |
| NCT04562129 | IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients | Melanoma Stage III | Recruiting |
| NCT05070403 | Study of Afatinib in Advanced Cutaneous Squamous Cell Carcinoma | Squamous Cell Carcinoma | Recruiting |
| NCT05524935 | Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma | Uveal Melanoma | Recruiting |
| NCT06137274 | Phase 2 Trial of Adaptive Radiotherapy Boost for HNSCC | Squamous Cell Carcinoma | Recruiting |
| NCT06295159 | Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma | Melanoma Stage III | Recruiting |
| NCT06553885 | Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC | Metastatic Colorectal Cancer | Recruiting |
| NCT06660368 | BCL2i CLAG-M in R/R Acute Myeloid Leukemia | Relapsed or Refractory Acute Myeloid Leukemia (AML) | Recruiting |
| NCT06833502 | Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer | Breast Cancer | Recruiting |
| NCT07007273 | Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma | Cutaneous Sarcoma | Recruiting |
| NCT06745882 | Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/… | Non-small Cell Lung Cancer | Recruiting |